8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-upOn behalf of the Bone Pain Trial Working Party

作者: J.R Yarnold

DOI: 10.1016/S0167-8140(99)00097-3

关键词:

摘要: Abstract Aim : To compare a single fraction of 8 Gy with course multifraction radiotherapy in terms long-term benefits and short-term side effects patients painful skeletal metastases. Methods Seven hundred sixty-five metastases requiring palliative were entered into prospective randomised clinical trial comparing regimen (20 Gy/5 fractions or 30 Gy/10 fractions). Patients recorded pain severity analgesic requirements on self-assessment questionnaires before treatment, at 2 weeks 1, 2, 3, 4, 5, 6, 8, 10 12 months after radiotherapy. Pain relief was the primary endpoint treatment benefit. Short-term side-effects compared subset 133 consecutive who graded nausea, vomiting antiemetic usage prior to daily intervals from days 1 14. Results Overall survival 44%, no statistically significant difference apparent between groups. There differences time first improvement pain, complete increase any up randomisation, nor class used. Retreatment twice as common than radiotherapy, although retreatment for residual recurrent did not reflect groups probability relief. The rate is thought greater readiness prescribe fraction, need. incidence vomiting, spinal cord compression pathological fracture two Conclusions A safe effective palliation metastatic bone least months. convenience lower cost make choice majority patients.

参考文章(10)
Keith Mostov, Zena Werb, Journey across the osteoclast Science. ,vol. 276, pp. 219- 220 ,(1997) , 10.1126/SCIENCE.276.5310.219
Ole Steen Nielsen, Søren M Bentzen, Erik Sandberg, Carl C Gadeberg, Adrian R Timothy, Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases Radiotherapy and Oncology. ,vol. 47, pp. 233- 240 ,(1998) , 10.1016/S0167-8140(98)00011-5
R. C. Coombes, P. Dady, C. Parsons, V. R. McCready, H. T. Ford, J.- C. Gazet, T. J. Powles, Assessment of response of bone metastases to systemic treatment in patients with breast cancer Cancer. ,vol. 52, pp. 610- 614 ,(1983) , 10.1002/1097-0142(19830815)52:4<610::AID-CNCR2820520406>3.0.CO;2-5
P. Price, P.J. Hoskin, D. Easton, D. Austin, S.G. Palmer, J.R. Yarnold, Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiotherapy and Oncology. ,vol. 6, pp. 247- 255 ,(1986) , 10.1016/S0167-8140(86)80191-8
M H Barcellos-Hoff, T A Dix, Redox-mediated activation of latent transforming growth factor-beta 1 Molecular Endocrinology. ,vol. 10, pp. 1077- 1083 ,(1996) , 10.1210/MEND.10.9.8885242
P.J. Hoskin, P. Price, D. Easton, J. Regan, D. Austin, S. Palmer, J.R. Yarnold, A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiotherapy and Oncology. ,vol. 23, pp. 74- 78 ,(1992) , 10.1016/0167-8140(92)90338-U
M H Barcellos-Hoff, R Derynck, M L Tsang, J A Weatherbee, Transforming growth factor-beta activation in irradiated murine mammary gland. Journal of Clinical Investigation. ,vol. 93, pp. 892- 899 ,(1994) , 10.1172/JCI117045
Mark N. Gaze, Charles G. Kelly, Gillian R. Kerr, Ann Cull, Valerie J. Cowie, Anna Gregor, Grahame C.W. Howard, Alan Rodger, Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules Radiotherapy and Oncology. ,vol. 45, pp. 109- 116 ,(1997) , 10.1016/S0167-8140(97)00101-1
Bennett A, The role of biochemical mediators in peripheral nociception and bone pain. Cancer surveys. ,vol. 7, pp. 55- 67 ,(1988)
Spielmann Rp, Crone-Münzebrock W, Quantification of recalcification of irradiated vertebral body osteolyses by dual-energy computed tomography. European Journal of Radiology. ,vol. 7, pp. 1- 5 ,(1987)